In addition, studies have shown that unaffected carriers of ATM mutations are more susceptible to BC compared to controls and have a lifetime BC risk of more than 25% (Renwick et al., 2006; Ahmed and Rahman, 2006). The gene discussed is ATM; the disease is breast cancer.